Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000038720 | SCV000062398 | benign | not specified | 2012-07-17 | criteria provided, single submitter | clinical testing | Gly421Gly in Exon 12 of LDB3: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue, is not located within the splice consensus sequence and has been identified in 0.9% (35/3738) of Afric an American chromosomes from a broad population by the NHLBI Exome Sequencing Pr oject (http://evs.gs.washington.edu/EVS; dbSNP rs139834701). |
Invitae | RCV000226780 | SCV000289615 | benign | Myofibrillar myopathy 4 | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621718 | SCV000735299 | benign | Cardiovascular phenotype | 2016-01-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001528760 | SCV001471479 | benign | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001528760 | SCV001893036 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001528760 | SCV004127012 | benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | LDB3: BS1, BS2 |
Prevention |
RCV003934930 | SCV004748700 | benign | LDB3-related disorder | 2019-02-22 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV001528760 | SCV001741070 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000038720 | SCV001919220 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001528760 | SCV001974351 | likely benign | not provided | no assertion criteria provided | clinical testing |